Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: E9AVX1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 175 | 179 | PF00656 | 0.409 |
CLV_C14_Caspase3-7 | 41 | 45 | PF00656 | 0.609 |
CLV_PCSK_KEX2_1 | 69 | 71 | PF00082 | 0.331 |
CLV_PCSK_PC1ET2_1 | 69 | 71 | PF00082 | 0.331 |
CLV_PCSK_SKI1_1 | 158 | 162 | PF00082 | 0.373 |
CLV_PCSK_SKI1_1 | 197 | 201 | PF00082 | 0.326 |
CLV_PCSK_SKI1_1 | 212 | 216 | PF00082 | 0.299 |
CLV_Separin_Metazoa | 10 | 14 | PF03568 | 0.581 |
DOC_CYCLIN_RxL_1 | 192 | 203 | PF00134 | 0.403 |
DOC_MAPK_MEF2A_6 | 197 | 206 | PF00069 | 0.270 |
DOC_PP2B_LxvP_1 | 249 | 252 | PF13499 | 0.402 |
DOC_USP7_MATH_1 | 186 | 190 | PF00917 | 0.481 |
DOC_USP7_MATH_1 | 40 | 44 | PF00917 | 0.731 |
DOC_USP7_UBL2_3 | 82 | 86 | PF12436 | 0.451 |
DOC_WW_Pin1_4 | 45 | 50 | PF00397 | 0.563 |
LIG_14-3-3_CanoR_1 | 158 | 164 | PF00244 | 0.312 |
LIG_14-3-3_CanoR_1 | 17 | 22 | PF00244 | 0.538 |
LIG_14-3-3_CanoR_1 | 212 | 220 | PF00244 | 0.301 |
LIG_14-3-3_CanoR_1 | 56 | 60 | PF00244 | 0.435 |
LIG_APCC_ABBA_1 | 145 | 150 | PF00400 | 0.389 |
LIG_APCC_ABBA_1 | 220 | 225 | PF00400 | 0.332 |
LIG_APCC_ABBAyCdc20_2 | 219 | 225 | PF00400 | 0.333 |
LIG_BIR_III_4 | 225 | 229 | PF00653 | 0.320 |
LIG_FHA_1 | 160 | 166 | PF00498 | 0.382 |
LIG_FHA_1 | 201 | 207 | PF00498 | 0.281 |
LIG_FHA_1 | 213 | 219 | PF00498 | 0.302 |
LIG_LIR_Nem_3 | 225 | 230 | PF02991 | 0.441 |
LIG_PDZ_Class_3 | 253 | 258 | PF00595 | 0.510 |
LIG_REV1ctd_RIR_1 | 81 | 90 | PF16727 | 0.330 |
LIG_SH2_SRC | 108 | 111 | PF00017 | 0.323 |
LIG_SH2_STAP1 | 108 | 112 | PF00017 | 0.315 |
LIG_SH2_STAP1 | 79 | 83 | PF00017 | 0.388 |
LIG_SH2_STAT5 | 135 | 138 | PF00017 | 0.498 |
LIG_SUMO_SIM_anti_2 | 198 | 203 | PF11976 | 0.334 |
LIG_SUMO_SIM_par_1 | 198 | 203 | PF11976 | 0.334 |
LIG_TRAF2_1 | 48 | 51 | PF00917 | 0.558 |
LIG_UBA3_1 | 199 | 207 | PF00899 | 0.325 |
LIG_WRC_WIRS_1 | 18 | 23 | PF05994 | 0.520 |
MOD_CK1_1 | 20 | 26 | PF00069 | 0.631 |
MOD_CK2_1 | 35 | 41 | PF00069 | 0.566 |
MOD_CK2_1 | 4 | 10 | PF00069 | 0.624 |
MOD_CK2_1 | 45 | 51 | PF00069 | 0.534 |
MOD_Cter_Amidation | 67 | 70 | PF01082 | 0.354 |
MOD_GlcNHglycan | 23 | 26 | PF01048 | 0.626 |
MOD_GlcNHglycan | 5 | 9 | PF01048 | 0.522 |
MOD_GSK3_1 | 13 | 20 | PF00069 | 0.558 |
MOD_GSK3_1 | 191 | 198 | PF00069 | 0.404 |
MOD_GSK3_1 | 28 | 35 | PF00069 | 0.413 |
MOD_GSK3_1 | 36 | 43 | PF00069 | 0.601 |
MOD_NEK2_1 | 200 | 205 | PF00069 | 0.246 |
MOD_NEK2_1 | 21 | 26 | PF00069 | 0.614 |
MOD_PKA_2 | 176 | 182 | PF00069 | 0.574 |
MOD_PKA_2 | 28 | 34 | PF00069 | 0.662 |
MOD_PKA_2 | 55 | 61 | PF00069 | 0.444 |
MOD_Plk_1 | 108 | 114 | PF00069 | 0.308 |
MOD_ProDKin_1 | 45 | 51 | PF00069 | 0.559 |
MOD_SUMO_rev_2 | 174 | 183 | PF00179 | 0.593 |
TRG_Pf-PMV_PEXEL_1 | 237 | 242 | PF00026 | 0.377 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4J7D9 | Bodo saltans | 49% | 76% |
A0A1X0NU43 | Trypanosomatidae | 39% | 72% |
A0A422N2C4 | Trypanosoma rangeli | 40% | 74% |
A4HCH6 | Leishmania braziliensis | 78% | 100% |
C9ZSQ1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 68% |
E9AH07 | Leishmania infantum | 95% | 100% |
Q4QBK8 | Leishmania major | 94% | 100% |
V5D4J4 | Trypanosoma cruzi | 39% | 75% |